Vertex (VRTX) Market Update
- Trading Performance (24‑hour period ending 09:49 PM CET, Friday 23 Oct 2026)
- Vertex shares increased 2.03 %.
- Current trading price: USD 525.86.
- Shares outstanding: 253.5 million.
- Market capitalization: USD 133 billion.
- Volume traded in last 24 hours: USD 878.3 million.
- Monthly change (since end of September): +3.65 %.
- 200‑day simple moving average: USD 477.17.
- 52‑week high: USD 560.25 (03 Sep 2026).
- 52‑week low: USD 403.16 (04 Nov 2025).
Recent Corporate Filings
- Form 3 and Form 4 (22 Oct 2026) –
- Filed by Vertex Pharmaceuticals, Inc. to disclose holdings of director Daniel Brennan.
- Form 3 establishes initial ownership; Form 4 records a subsequent purchase of a small block of common stock.
- Accompanying power‑of‑attorney statement authorizes representatives to file on Mr. Brennan’s behalf.
- No additional corporate actions or governance changes are reported.
Comparative Performance of Related Stocks (Last 24 Hours)
| Ticker | Direction | Price (USD) | Market Cap (USD bn) | P/E | Notes |
|---|---|---|---|---|---|
| SCCO | Down 7.31 % | 185.11 | 155 | 29.33 | Grupo Mexico to increase investment in U.S. copper unit Asarco; expansion of Ray and Silver Bell mines in Arizona; restart of Hayden smelter. |
| ISRG | Up 3.67 % | 452.31 | 151.3 | 51.79 | Unaudited Q1 2026 results: revenue growth in product and service segments; operating profit solid; cash balance strong; share repurchases noted. |
| UBER | Up 2.14 % | 66.88 | 138.1 | 14.84 | Investor activity ahead of upcoming earnings; regulatory scrutiny from FTC over subscription cancellation; options trading indicates market expectations of short‑term volatility. |
| SCHW | Down 0.22 % | 90.80 | 158.1 | 15.62 | Quarterly cash dividend announced for common shareholders (late Nov); preferred dividend payable early Dec; CEO panel on advisory growth at IMPACT 2026 conference. |
Company Overview
Vertex Pharmaceuticals Incorporated is a biotechnology firm headquartered in Boston, Massachusetts. The company researches, develops, and commercializes therapies for cystic fibrosis, cancer, inflammatory bowel disease, autoimmune disorders, and neurological conditions. Vertex was founded in 1991 and listed on the Nasdaq exchange on 24 July 1991. The company’s website is www.vrtx.com .
